恒升医学 (874056.OC)

+ 收藏

现金流量表(恒升医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年三季报2023年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 102,746,960.63367,787,580.00226,569,620.61163,383,122.53
 收到的税费返还(元) 46,362.47390,482.75381,518.22381,518.22
 收到其他与经营活动有关的现金(元) 2,237,313.823,413,983.832,323,948.511,472,767.25
 经营活动现金流入小计(元) 105,030,636.92371,592,046.58229,275,087.34165,237,408.00
 购买商品、接受劳务支付的现金(元) 47,507,488.0873,367,491.7757,420,007.2144,159,616.28
 支付给职工以及为职工支付的现金(元) 36,091,864.8468,013,667.9451,669,089.2434,809,831.19
 支付的各项税费(元) 14,084,095.6539,109,938.3432,974,373.7125,785,822.65
 支付其他与经营活动有关的现金(元) 16,635,777.8734,225,257.8528,640,109.4319,698,363.63
 经营活动现金流出小计(元) 114,319,226.44214,716,355.90170,703,579.59124,453,633.75
 经营活动产生的现金流量净额(元) -9,288,589.52156,875,690.6858,571,507.7540,783,774.25
二、投资活动产生的现金流量
 收回投资收到的现金(元) 345,000,000.00168,707,401.0296,700,000.0065,700,000.00
 取得投资收益收到的现金(元) 1,171,178.35788,827.08382,241.91223,752.61
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 3,200.0038,145.20--
 投资活动现金流入小计(元) 346,174,378.35169,534,373.3097,082,241.9165,923,752.61
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,092,932.006,038,179.314,607,853.893,085,040.90
 投资支付的现金(元) 341,000,000.00244,507,401.02136,500,000.0075,500,000.00
 投资活动现金流出小计(元) 342,092,932.00250,545,580.33141,107,853.8978,585,040.90
 投资活动产生的现金流量净额(元) 4,081,446.35-81,011,207.03-44,025,611.98-12,661,288.29
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) -10,080,000.0010,080,000.0010,080,000.00
 取得借款收到的现金(元) 1,740,000.004,660,000.004,660,000.003,830,000.00
 收到其他与筹资活动有关的现金(元) 145,226.67338,000.83338,000.83336,666.08
 筹资活动现金流入小计(元) 1,885,226.6715,078,000.8315,078,000.8314,246,666.08
 偿还债务支付的现金(元) 1,830,000.007,812,000.007,812,000.004,982,000.00
 分配股利、利润或偿付利息支付的现金(元) 29,568.059,423,706.189,412,870.459,380,159.15
 支付其他与筹资活动有关的现金(元) 1,770,961.504,972,420.351,509,823.73846,466.85
 筹资活动现金流出小计(元) 3,630,529.5522,208,126.5318,734,694.1815,208,626.00
 筹资活动产生的现金流量净额(元) -1,745,302.88-7,130,125.70-3,656,693.35-961,959.92
四、汇率变动对现金及现金等价物的影响(元) -572.04--
五、现金及现金等价物净增加额(元) -6,952,446.0568,734,929.9910,889,202.4227,160,526.04
 加:期初现金及现金等价物余额(元) 116,009,322.9047,274,392.9147,274,392.9147,274,392.91
 期末现金及现金等价物余额(元) 109,056,876.85116,009,322.9058,163,595.3374,434,918.95
补充资料:
 净利润(元) 7,232,073.0941,396,732.34-22,263,500.00
 资产减值准备(元) 3,079,843.85-5,807,686.53-1,470,900.00
 固定资产和投资性房地产折旧(元) 2,403,958.835,089,130.96-2,368,400.00
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,403,958.835,089,130.96-2,368,400.00
 无形资产摊销(元) 1,579,491.823,247,678.95-1,637,100.00
 长期待摊费用摊销(元) 1,321,962.522,349,844.25-1,037,000.00
 处置固定资产、无形资产和其他长期资产的损失(元) 30,776.40-81,399.44-10,800.00
 固定资产报废损失(元) 10,162.5137,245.49-3,000.00
 公允价值变动损失(元) -133,880.75-66,149.08--89,500.00
 财务费用(元) 140,198.32577,175.79-339,600.00
 投资损失(元) -994,369.75-788,827.08--223,800.00
 递延所得税(元) -1,287,874.603,536,401.02-47,100.00
  其中:递延所得税资产减少(元) -1,290,266.103,823,218.95-88,200.00
 递延所得税负债增加(元) 2,391.50-286,817.93--41,100.00
 存货的减少(元) 703,671.0713,724,299.09-6,146,700.00
 经营性应收项目的减少(元) -26,519,727.08109,005,195.81-22,129,100.00
 经营性应付项目的增加(元) 1,938,378.43-20,409,583.85--18,699,500.00
 其他(元) -216,042.072,150,759.95--351,000.00
 现金的期末余额(元) 109,056,876.85116,009,322.90--
 减:现金的期初余额(元) 118,206,964.0247,274,392.91--
 现金及现金等价物的净增加额(元) -6,952,446.0568,734,929.99-27,160,526.04
公告日期 2024-08-282024-04-292023-12-192023-08-29
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院